Mereo Biopharma

London, United Kingdom

Mereo is a new UK-based speciality biopharmaceutical company.

$50.0M raised

Jun 2024

Post-IPO Equity

Biopharma Biotechnology Health Care Innovation Management

Top Investors

Vivo Capital Janus Henderson Investors Perceptive Advisors Samsara BioCapital Rock Springs Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mereo Biopharma

How much funding has Mereo Biopharma raised?

Mereo Biopharma has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.

Who are Mereo Biopharma's investors?

Mereo Biopharma's investors include Vivo Capital, Janus Henderson Investors, Perceptive Advisors, Samsara BioCapital, Rock Springs Capital.

Where is Mereo Biopharma headquartered?

Mereo Biopharma is headquartered in London, United Kingdom.

What does Mereo Biopharma do?

Mereo is a new UK-based speciality biopharmaceutical company.

What stage is Mereo Biopharma at?

Mereo Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 14, 2024.

MLA

"Mereo Biopharma — Funding & Investors." VCBacked, June 14, 2024, https://www.vcbacked.co/company/mereo-biopharma. Accessed July 2, 2026.

APA

VCBacked. (2024). Mereo Biopharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mereo-biopharma

Wikipedia (cite web)

{{cite web |title=Mereo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/mereo-biopharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 14, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.